Haemonetics | HAE - SCHULD

Aktienkurs
59.93
Täglich Wechseln
0.31 0.52%
Monatlich
7.15%
Jährlich
-4.13%
Q2 Prognose
58.65




SCHULD Veränderung Datum
Avanos Medical USD 133.7M 3.6M 2025-09
Baxter International USD 9.71B 13M 2025-09
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Cerus USD 84.16M 791K 2024-12
Cooper Companies USD 2.51B 27M 2025-09
Fresenius EUR 12.85B 778M 2025-06
Fresenius Medical Care EUR 10.8B 322.94M 2025-12
Globus Medical USD 119.34M 1.76M 2025-09
Haemonetics USD 1.22B 54K 2025-09
ICU Medical USD 1.28B 79.88M 2025-12
Intuitive Surgical USD 0 0 2025-03
Masimo USD 586.2M 56M 2025-09
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.15M 599K 2025-09
Neogen USD 792.93M 396K 2025-09
OraSure Technologies USD 782K 465K 2024-06
Plus Therapeutics USD 3.98M 372K 2023-12
Quidel USD 2.84B 51.1M 2025-09
ResMed USD 846.35M 178.06M 2025-09
STAAR Surgical USD 39.12M 1.4M 2025-09
Steris USD 2.06B 10.4M 2025-09
Stryker USD 14.86B 1.74B 2025-12
Surmodics USD 29.55M 111K 2024-09
Teleflex USD 2.77B 774M 2025-09
Terumo JPY 159.87B 14.97B 2025-09
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
US Physical Therapy USD 162.46M 2.2M 2025-12
Zimmer Biomet Holdings USD 7.52B 593.5M 2025-12